Sean P. Nolan
Chief Executive Officer at Taysha Gene Therapies Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Taysha Gene Therapies Inc., 3 years.
Taysha Gene Therapies Inc.
Director · Chief Executive Officer
Ventas Inc.
Director
Chief executive roles
Taysha Gene Therapies Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 13, 2026 | Ventas Inc. | Grant or award | +2,047 | $90.35 | $184,946 |
| Jan 26, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −41,312 | $4.61 | $190,448 |
| Jan 23, 2026 | Taysha Gene Therapies Inc. | Open-market sale | −136,789 | $4.75 | $649,748 |
| Jan 12, 2026 | Taysha Gene Therapies Inc. | Grant or award | +1,008,000 | — | — |
| May 13, 2025 | Ventas Inc. | Grant or award | +2,882 | $64.18 | $184,967 |
| Jan 2, 2025 | Taysha Gene Therapies Inc. | Grant or award | +892,500 | — | — |
| May 14, 2024 | Ventas Inc. | Grant or award | +3,648 | $47.96 | $174,958 |
| Jan 2, 2024 | Taysha Gene Therapies Inc. | Grant or award | +1,184,688 | — | — |
| Aug 16, 2023 | Taysha Gene Therapies Inc. | Open-market purchase | +444,444 | $0.90 | $400,000 |
| May 16, 2023 | Ventas Inc. | Grant or award | +3,835 | $45.63 | $174,991 |
| Jul 21, 2020 | Ventas Inc. | Open-market purchase | +27 | $34.21 | $924 |
| Jul 21, 2020 | Ventas Inc. | Open-market purchase | +37 | $34.21 | $1,266 |
| Apr 20, 2020 | Ventas Inc. | Open-market purchase | +36 | $27.70 | $997 |
| Apr 20, 2020 | Ventas Inc. | Open-market purchase | +50 | $27.70 | $1,385 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.